Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MIRACLE

Financiado

Mid infrared arthroscopy innovative imaging system for real time clinical in dep...

Mid infrared arthroscopy innovative imaging system for real time clinical in depth examination and diagnosis of degenerative joint diseases MIRACLE will take towards commercialization the first mid-infrared (MIR) arthroscopy probe for in-depth evaluation of articular cartilage enabling early diagnosis of degenerative joint diseases such as osteoarthritis (OA). The pro... ver más

31/03/2022

UOULU

7M€

Presupuesto del proyecto: 7M€

Líder del proyecto

OULUN YLIOPISTO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 15 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-03-31

ICT-30-2017: Photonics KET 2017

I+D

Cerrada hace 7 años

0% 88% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

15 Participantes

UOULU

1.18M€ | Lider

SUPERS DIANA

117.72K€ | Participante

INEB

320.85K€ | Participante

OptoPrecision

495.62K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

MUOTO Commercialization of 3D histopathological evaluation of oste... 150K€ Cerrado

CPP2021-008422 Abordaje multidisciplinar para el desarrollo de herramientas... 155K€ Cerrado

DPI2016-80283-C2-2-R CARACTERIZACION CLINICA, RADIOLOGICA Y ANALITICA DEL PACIENT... 168K€ Cerrado

IseeG FunctIonal optoacousticS for imaging Early onsEt of Gut infl... 1M€ Cerrado

PID2021-126469OB-C22 DESCRIPCION DE FENOTIPOS DE ARTROSIS DE RODILLA BASANDOSE EN... 164K€ Cerrado

FRONTIER From Research Optoacoustic Novelty To Imaging Established in... 4M€ Cerrado

Duración del proyecto: 51 meses Fecha Inicio: 2017-12-19
Fecha Fin: 2022-03-31

Líder del proyecto

OULUN YLIOPISTO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 7M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto MIRACLE will take towards commercialization the first mid-infrared (MIR) arthroscopy probe for in-depth evaluation of articular cartilage enabling early diagnosis of degenerative joint diseases such as osteoarthritis (OA). The proposed device is intended for use during a minimally invasive surgery (arthroscopy). Currently, the surgeon’s decision-making is based on visual inspection and manual probing of the cartilage tissue which is highly subjective and of poor repeatability. Untreated or not-correctly treated joint injury will most likely progress towards OA, which will lead to joint pain, movement limitation, joint failure, and ultimately disability and joint replacement. OA constitutes a major challenge for the health systems and affects 242 million people globally. Moreover, OA is highly prevalent in Europe with an estimated 19.7-42.3% in the elderly population. MIRACLE concept is to access the biochemical on articular cartilage, which precedes OA. The feasibility of this approach as a diagnostic method has been demonstrated by MIRACLE consortium (TRL4). MIRACLE has also prototyped a MIR-probe with potential use for diagnostics (TRL4). By technology development reaching TRL 6-7, MIRACLE will bring to the arthroscopy market the first MIR-based probe providing an unique, accurate and quantitative diagnostic tool for the orthopedic surgeon. This will be achieved combining three novel photonics components: (i) a quantum cascade laser array tailored to biodiagnostics, (ii) an on-chip beam combiner for efficient radiation coupling, and (iii) MIR sensing probe for imaging. These components will be integrated in a medical device to be placed in the arthroscopy market (valued at $4 billion in 2015). In addition to add value to the European medical equipment industry, MIRACLE strives towards cost reduction of OA patients (currently costs/patient/year €10,452) contributing to more affordable public health care and promoting wellbeing in the European ageing population.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores